Despite recent advances in cancer medication, malignant tumors continue to be the second leading cause of death worldwide. Furthermore, introducing a therapeutic compound with low-side effects as well as low-price for consumers is controversial. Recent efforts have been focusing on traditional medicines as a rich source of herbal agents. Curcumin, the major turmeric phytochemical, has been widely assessed as an anti-cancer compound in vitro and in vivo. However, the use of curcumin in cancer treatment has limitations because of its low solubility, poor tissue absorption, rapid metabolism and rapid systemic elimination. Recent work has focused on improving the stability of curcumin to facilitate clinical application. Dendrosomal nano-corcumin (DNC) is one of the most successful compounds showing significant cellular absorption and also anti-tumor effects. The present overview of newest applicable strategies for curcumin-based therapy and their clinical potential usefulness has the emphasis on DNC.
Mollaei, H., & Babaei, E. (2017). Therapeutic Potential of Novel Nano-Based Curcumin Compounds In Vitro and In Vivo. Asian Pacific Journal of Cancer Prevention, 18(4), 885-888. doi: 10.22034/APJCP.2017.18.4.885
MLA
Homa Mollaei; Esmaeil Babaei. "Therapeutic Potential of Novel Nano-Based Curcumin Compounds In Vitro and In Vivo". Asian Pacific Journal of Cancer Prevention, 18, 4, 2017, 885-888. doi: 10.22034/APJCP.2017.18.4.885
HARVARD
Mollaei, H., Babaei, E. (2017). 'Therapeutic Potential of Novel Nano-Based Curcumin Compounds In Vitro and In Vivo', Asian Pacific Journal of Cancer Prevention, 18(4), pp. 885-888. doi: 10.22034/APJCP.2017.18.4.885
VANCOUVER
Mollaei, H., Babaei, E. Therapeutic Potential of Novel Nano-Based Curcumin Compounds In Vitro and In Vivo. Asian Pacific Journal of Cancer Prevention, 2017; 18(4): 885-888. doi: 10.22034/APJCP.2017.18.4.885
)